Condition-Based Supplement Claim Decisions Urged By CSPI
This article was originally published in The Tan Sheet
Executive Summary
FDA's determination of whether a dietary supplement claim is an acceptable structure/function claim should be based solely on the type of condition a product professes to benefit, Center for Science in the Public Interest attorney Ilene Heller said at an FDA meeting on supplement claims in Washington, D.C. Aug. 4.
You may also be interested in...
NLEA v. FDA Proposed Rule Definitions of Disease
Nutrition Labeling & Education Act (21 CFR 101.14(a)(6)) Definition:
Disclaimers May Be "Subterfuge" For Disease Claims, PhRMA Exec Warns
FDA should be cautious in allowing a disclaimer statement that could mislead consumers into believing dietary supplements can cure or prevent disease, a PhRMA rep maintained at FDA's Aug. 4 public meeting on the regulation of supplement structure/ function claims in Washington, D.C.
Disclaimers May Be "Subterfuge" For Disease Claims, PhRMA Exec Warns
FDA should be cautious in allowing a disclaimer statement that could mislead consumers into believing dietary supplements can cure or prevent disease, a PhRMA rep maintained at FDA's Aug. 4 public meeting on the regulation of supplement structure/ function claims in Washington, D.C.